meningococcal group C vaccine
GPTKB entity
Statements (23)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
gptkb:vaccine
|
| gptkbp:broadcastOn |
multiple doses
|
| gptkbp:contains |
gptkb:polysaccharide_antigen
conjugate protein |
| gptkbp:contraindication |
severe allergic reaction to previous dose
|
| gptkbp:introducedIn |
late 1990s
|
| gptkbp:prevention |
meningococcal disease
Neisseria meningitidis group C infection |
| gptkbp:recommendation |
gptkb:World_Health_Organization
|
| gptkbp:reduces |
carriage of Neisseria meningitidis group C
incidence of group C meningitis |
| gptkbp:routeOfAdministration |
intramuscular injection
|
| gptkbp:sideEffect |
fever
headache injection site pain |
| gptkbp:type |
gptkb:vaccine
|
| gptkbp:usedFor |
adolescents
children adults at risk |
| gptkbp:usedIn |
immunization programs
|
| gptkbp:bfsParent |
gptkb:meningococcal_group_C_polysaccharide
|
| gptkbp:bfsLayer |
8
|
| https://www.w3.org/2000/01/rdf-schema#label |
meningococcal group C vaccine
|